Skip to content

A multicenter randomized controlled study on the effect of regulating the mind and enhancing intelligence acupuncture on cognitive function in elderly individuals with mild cognitive impairment and amnesia

A multicenter randomized controlled study on the effect of regulating the mind and enhancing intelligence acupuncture on cognitive function in elderly individuals with mild cognitive impairment and amnesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080456
Enrollment
Unknown
Registered
2024-01-30
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

amnestic mild cognitive impairment

Interventions

Acupuncture group:Select acupoints such as Si Shen Cong, Yin Tang, Neiguan, Feng Long, San Yin Jiao, Tai Xi, and Tai Chong (derived from Academician Shi Xuemin's Little Awakening Brain Prescription).
False needle group:The treatment course of the sham acupuncture group is the same as that of the acupuncture group. Choose non meridian and non acupoint shallow needling method for operation, avoid me
control group:Health Education

Sponsors

Shenzhen Bao'an District People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Meets the above diagnostic criteria; ? Age range from 60 to 75 years old; ? Native Chinese, right-handed, with at least elementary education; ? Compared to the normal state within the past 5 years, there is a subjective sustained decline in memory or cognitive function, which has been confirmed by its nursing staff. ? Daily living ability (ADL) remains normal, with a score of = 18 on the ADL scale (14 items), informed consent, and voluntary participation. ? Only those who meet all the inclusion criteria mentioned above can be enrolled.

Exclusion criteria

Exclusion criteria: ? Having a positive history of neurological disorders (such as traumatic brain injury, stroke, Parkinson's disease, multiple sclerosis); Treatment that affects cognitive function (such as the treatment of acute psychiatric attacks, the treatment of memantines, rivastatin, and donepezil); ? There is a significant history of mental illness (such as bipolar disorder, schizophrenia) or severe anxiety and depression; ? Existence of serious heart, kidney, liver, gastrointestinal, infectious, endocrine diseases or cancer; ? Severe visual and auditory impairments that prevent neuropsychological evaluation; ? He received acupuncture and moxibustion treatment within three months. Those who meet one of the above conditions will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Situational memory assessment:auditory verbal learning test, AVLT- H;

Secondary

MeasureTime frame
Cognitive function assessment:WMS,Digit Span Subtest,Digit Symbol-Coding,MoCA;Imaging omics testing:fMRI,EEG,fNIRS;

Countries

China

Contacts

Public ContactChen Shangjie

Shenzhen Bao'an District People's Hospital

csjmesz@sina.com+86 158 9979 7851

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026